The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Keith D. Dawkins

Showing 1-20 of 37 articles
Stable CAD
The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial
Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A
May 20, 2018 | 10.4244/EIJ-D-17-00620
Impact of bioresorbable versus permanent polymer on long-term vessel wall inflammation and healing: a comparative drug-eluting stent experimental study
Wilson G, McGregor J, Conditt G, Shibuya M, Sushkova N, Eppihimer M, Hawley S, Rousselle S, Huibregtse B, Dawkins K, Granada J
February 20, 2018 | 10.4244/EIJ-D-17-00332
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco D, Zhang M, Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
Coronary interventions
Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?
Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M
September 20, 2017 | 10.4244/EIJ-D-16-00991
Coronary interventions
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy
Kereiakes D, Meredith I, Masotti M, Carrié D, Moreno R, Erglis A, Mehta S, Elhadad S, Berland J, Stein B, Airaksinen J, Jobe R, Reitman A, Janssens L, Christen T, Dawkins K, Windecker S
March 20, 2017 | 10.4244/EIJ-D-16-00643
Peripheral interventions
Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model
Hou D, Huibregtse B, Eppihimer M, Stoffregen W, Kocur G, Hitzman C, Stejskal E, Heil J, Dawkins K
August 20, 2016 | 10.4244/EIJV12I6A128
Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study
Watkins S, Oldroyd K, Preda I, Holmes D, Colombo A, Morice M, Leadley K, Dawkins K, Mohr F, Serruys P, Feldman T
April 20, 2015 | 10.4244/EIJV10I12A244
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_01
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_07
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I, Worthley S, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco D, Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P
December 27, 2013 | 10.4244/EIJV9I8A170
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P
March 22, 2013 | 10.4244/EIJV8I11A196
Boston Scientific Lotus valve
Meredith I, Hood K, Haratani N, Allocco D, Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study
Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen J, King III S, Chronos N, Eppihimer M, Huibregtse B, Dawkins K, Hou D
August 24, 2012 | 10.4244/EIJV8I4A77
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D, Popma J, Cannon L, Kandzari D, Kimmelstiel C, Meredith I, Teirstein P, Verheye S, Allocco D, Dawkins K, Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries
Wilson G, Huibregtse B, Pennington D, Dawkins K
June 27, 2012 | 10.4244/EIJV8I2A39
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)
Morice M, Feldman T, Mack M, Stahle E, Holmes D, Colombo A, Morel M, van den Brand M, Serruys P, Mohr F, Carrié D, Fournial G, James S, Leadley K, Dawkins K, Kappetein A
October 28, 2011 | 10.4244/EIJV7I6A109

Latest news

NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021
News
Don’t Miss #EIJOnAir 2nd Edition!
Elective cardiac invasive procedures during the COVID-19 outbreak
March 4, 2021
Ahead of Print
MitraClip for a range of LV dysfunction and secondary MR
Stamatios Lerakis et al.
March 2, 2021
Editorial
Thrombolysis in ST-elevation myocardial infarction is not dead
Petr Kala et al.
March 2, 2021
SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH
(Thanks to the support of Biotronik)
February 28, 2021
JAA
This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...
March 2, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke